Forbes February 13, 2025
Jennifer Kite-Powell

Endometriosis is a chronic inflammatory disease that impairs the health and quality of life for more than one in ten women who are of reproductive age, around 190 million women globally.

Endometriosis symptoms often emerge in young adulthood, impacting education, career, and fertility. Current first-line treatments, including pain medications and hormonal contraceptives, provide inadequate relief for many patients or cause intolerable side effects.

It takes an average of seven years, and at least seven different doctors before a woman can receive a definitive diagnosis of endometriosis. Dr. Laura Homewood, a Gynecologist Surgeon at UVA Health appeared on PBS News Hour in February as a part of their ongoing series Unequal Treatment about the difficulties in getting a diagnosis since because...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Investments, Pharma, Pharma / Biotech, Trends
Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker
Walgreens PE deal back on the table: 5 things to know
Stakeholder Management and Interoperability of Biosimilars
Anne Wojcicki has a new offer to take 23andMe private, this time for $74.7 million
Pharma Pulse 2/21/25: RWE in Medical Research and Drug Development, Inhaled Antibody Therapy for RSV & more

Share This Article